Skip to main content
. Author manuscript; available in PMC: 2019 Feb 25.
Published in final edited form as: J Alzheimers Dis. 2018;66(3):947–970. doi: 10.3233/JAD-180164

Table 1.

Participant baseline characteristics: RCT of a 12-week Kirtan Kriya meditation (KK) versus a 12-week music listening (ML) program in older adults with subjective cognitive decline (N = 53)

Overall (N = 53)
KK (n = 25)
ML (n = 28)
p
N % N % N %
Demographic characteristics
Age (range 5084 y)
 Mean ± SE 60.47 ± 1.17 60.71 ± 1.38 60.20 ± 1.63 0.81
Female Gender 46 86.79% 23 92.00% 23 82.14% 0.29
Race/Ethnicity: Non-Hispanic White 50 94.34% 23 92.00% 27 96.43% 0.49
Education12 y 43 81.13% 22 88.00% 21 75.00% 0.23
Employment status 0.47
 Employed full or part time 40 75.47% 21 84.00% 19 76.00%
 Retired/Homemaker/Other 13 24.53% 4 16.00% 9 36.00%
Marital status 0.37
 Married/co-habiting 34 64.15% 16 64.00% 18 64.29%
 Divorced/widowed/separated/single 19 35.85% 9 36.00% 10 35.71%
Lifestyle and health-related factors
Smoking status: Ever smoked 20 37.74% 11 44.00% 9 32.14% 0.37
Caffeinated beverage consumption
Mean oz consumed/day ± SE 22.83 ± 2.40 24.31 ± 3.39 21.52 ± 3.42 0.57
Physical activity 0.81
 None 14 26.42% 7 28.00% 7 25.00%
Mean minutes/week ± SE 117.28 ± 16.25 112.70 ± 18.47 121.37 ± 26.29 0.79
Body mass index (BMI)
 Obese (BMI ≥30) 24 45.28% 8 32.00% 16 57.14% 0.07
 Mean ± SE 29.74 ± 1.05 28.74 ± 1.34 30.63 ± 1.58 0.37
History of diagnosed:
 Diabetes 9 16.98% 4 16.00% 5 17.86% 0.85
 Hypertension 17 32.08% 7 28.00% 10 35.71% 0.35
 High cholesterol 31 58.49% 17 68.00% 14 50.00% 0.18
 Depression 18 33.96% 10 40.00% 8 28.57% 0.38
 Anxiety 16 30.19% 8 32.00% 8 28.57% 0.78
Number of cardiometabolic AD risk factors*
 Mean ± SE 1.81 ± 0.17 1.76 ± 0.27 1.86 ± 0.23 0.78
Total number of major modifiable risk factors for AD**
 Mean ± SE 2.77 ± 0.20 2.72 ± 0.32 2.82 ± 0.25 0.80
Number of medications (regular use) 0.67
 None 29 54.72% 14 56.00% 15 53.57%
 One 13 24.53% 5 20.00% 8 28.57%
 Two or more 11 20.75% 6 24.00% 5 17.86%
History of hormone replacement therapy‡‡ 17 33.33% 6 23.08% 11 44.00% 0.13
*

Including diabetes, hypertension, high cholesterol, obesity (BMI ≥ 30), cardiovascular disease.

**

Also including history of depression or anxiety disorder, current smoking, and lack of physical activity.

Including those commonly linked to memory changes: Statins, narcotic analgesics, steroids, benzodiazepines, beta blockers, antihistamines, anticonvulsants, tricyclic and other non-SSRI/SNRI antidepressants.

‡‡

Percentages calculated in women only.